Ruopeng Su

机构：Shanghai Jiao Tong University, Renji Hospital · ORCID：0000-0002-8160-3959

发表论文 35 篇 · 总被引 271 次 · h-index 9

代表论文

The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer (2023 · Nature Communications · 被引 22)
Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer (2025 · Journal of Experimental & Clinical Cancer Research · 被引 12)
Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming (2025 · Cancer Discovery · 被引 6)
Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy (2023 · Urologic Oncology Seminars and Original Investigations · 被引 6)
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study (2024 · Cancer Medicine · 被引 4)
Clinical outcomes of immune checkpoint inhibitor plus nab-paclitaxel in metastatic upper tract urothelial carcinoma (2023 · Translational Andrology and Urology · 被引 4)